FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy

If approved, eli-cel will be the first and only gene therapy for the treatment of early active CALD, a rare neurodegenerative disease that primarily affects young children and leads to irreversible loss of neurologic function and death PDUFA goal date is set for September 16, 2022 SOMERVILLE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) today announced … [Read more…]

Arthritis National Research Foundation Announces 2022-23 Grant Recipients

Early-career scientists receive funding to pursue arthritis and related autoimmune disease research IRVINE, Calif.–(BUSINESS WIRE)–The Arthritis National Research Foundation (ANRF) today announced the 19 early-career scientists who will receive grant funding and make up the 2022-23 cohort. The eight first-year grantees will each receive $100,000 and for the first time, second year grantees will be … [Read more…]

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Branded Pharmaceutical Products R&D, Inc. and Auspex Pharmaceuticals, Inc., U.S. affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), have reached an agreement with Aurobindo to resolve the dispute over Aurobindo’s Abbreviated New Drug Application (“ANDA”) for a generic deutetrabenazine product. Teva and Aurobindo have been involved … [Read more…]

Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care

At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare proudly showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer This includes a new cyclotron Solid Target Platform which increases Gallium-68 production and access – a radioisotope used in molecular imaging for prostate cancer diagnosis, staging … [Read more…]

Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering

HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today the closing of its rights offering and the final results thereof. The Company received basic subscriptions and over-subscriptions in excess of the $15 million limit in … [Read more…]

With New Funding, Phase Genomics Seeks to Eliminate One of Biology’s Biggest Blind Spots

Armed with the world’s largest virus-bacteria interactome repository, Phase Genomics to engineer a predictive engine for the development of new therapies against drug-resistant biothreats SEATTLE–(BUSINESS WIRE)–#metagenomics—Phase Genomics, Inc., a leading developer of proximity ligation-based genomic solutions, today announced $5.5MM in combined non-dilutive funding from the Bill and Melinda Gates Foundation and the National Institute of … [Read more…]

Phibro Issues Inaugural Environmental, Social and Governance Report

TEANECK, N.J.–(BUSINESS WIRE)–Phibro Animal Health Corporation (Nasdaq: PAHC), a diversified global developer, manufacturer, and supplier of a broad range of animal health and mineral nutrition products for livestock, published its inaugural Environmental, Social and Governance (ESG) Report (the “Report”). The Report establishes Phibro’s baseline on certain key performance indicators as of December 31, 2021, by … [Read more…]

Endoluxe Enters Into Multi-year USA Distribution Agreement With Dornier MedTech for Urology Segment

MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe is pleased to announce that they have entered into a multi-year exclusive distribution agreement specifically for the urology market with Dornier MedTech. Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value. “We are absolutely ecstatic to partner with Dornier MedTech to address the growing … [Read more…]

NEXT Molecular Analytics Receives Accreditation from the New York State Department of Health for its L-Asparaginase Enzyme Activity Assay Platform

CHESTER, Va.–(BUSINESS WIRE)–NEXT Bio Research Services LLC (www.nextmolecular.com), dba NEXT Molecular Analytics is pleased to announce that the New York State Department of Health (NYSDOH) has accredited the Company’s L-Asparaginase enzyme activity assay platform. This means that NEXT is now able to receive clinical test samples from New York State institutions without waiver and also … [Read more…]

Churchill Downs Reduces Risk of Virus Transmission with Pyure Air & Surface Purification Technology

Study shows reduced risk of virus transmission, including COVID-19 BOYNTON BEACH, Fla.–(BUSINESS WIRE)–Churchill Downs Racetrack is known as the home of the Kentucky Derby, The Greatest Two Minutes in Sports. However, the Kentucky Derby is just one part of a larger, diversified horse racing, online wagering and gaming entertainment company, Churchill Downs Incorporated (CDI). In … [Read more…]